You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Patient voice: The label given to my MS disease course matters to me—Yes

Multiple Sclerosis Journal

Impact Factor: 5.0 / 5-Year Impact Factor: 5.2

Journal Homepage Submission guidelines

Restricted access

Research article

First published online March, 2026

Patient voice: The label given to my MS disease course matters to me—Yes

Volume 32, Issue 3

https://doi.org/10.1177/13524585251396262

Abstract

Get full access to this article

View all access options for this article.

References

1.

Lublin

FD

Reingold

SC.

Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907–911.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Novel MRI metrics: Is targeting brain atrophy a practical treatment goal? Yes

Retricted access

Data handling in clinical trials: an ongoing debate

Retricted access

Retricted access

Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination